Rona Therapeutics China

Financing led by LongRiver Investments with participation by new and existing global investment fundsRona will use proceeds to progress leading metabolic siRNA pipeline programs into global development and expand extra-hepatic delivery platform in CNS and beyondor contact: BD@ronatherapeutics.com 

View original content:https://www.prnewswire.co.uk/news-releases/rona-therapeutics-raises-35-million-series-a-financing-to-advance-innovative-metabolic-sirna-pipeline-in-clinic-and-next-generation-rna-platforms-302200573.html